Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

NZ Biomedical Researchers Showcase Their Work

New Zealand Biomedical Researchers Showcase Their Work

Leading New Zealand biomedical researchers are show-casing their work to international pharmaceutical companies at a meeting opening in Wellington today.

“The New Zealand Biomedical R&D Showcase” is sponsored by the Minister for Research, Science and Technology, Pete Hodgson. It is jointly chaired by the Chairman of the Researched Medicines Industry (RMI), Richard Nottage, and Dr Paul Reynolds, Chief Policy Adviser at the Ministry of Research, Science and Technology.

Dr Reynolds said, “The meeting is an opportunity for New Zealand researchers to inform the international pharmaceutical industry about the scope of our biomedical research. It will explore the potential to develop and grow our biomedical research industry.”

Over the next two days the meeting will cover the New Zealand policy environment, drug discovery and development, clinical research, gene and protein-based research, and animal-based biomedical research that takes place in this country.

RMI Chairman Richard Nottage said, “It has taken considerable effort on the part of the pharmaceutical industry to bring together some of their most senior research directors in support of the Government’s knowledge economy drive.

“We hope this meeting represents the first of similar, but smaller, commercially-focussed discussions which will need to occur if the New Zealand biotech industry is to grow significantly and to have a viable, long term future.

The presenters have been drawn from a variety of New Zealand’s public and private research entities. They include notable figures such as cancer researcher Prof William Denny, Genesis Chief Executive, Dr Jim Watson, Malaghan Institute Director, Professor Graham Le Gros, and Dean of the Auckland Medical School, Professor Peter Gluckman.

The participants include pharmaceutical company research directors from the United States, United Kingdom, Australia and New Zealand representing major international pharmaceutical companies, such as Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Pfizer and Wyeth.

Ends



© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Electricity Market: Power Panel Favours Scrapping Low-Fixed Charges

An independent panel reviewing electricity prices favours scrapping the government’s low-user fixed charge regime, banning the use of prompt-payment discounts, and requiring greater disclosure of the profit split between the retail and generation arms of the major power companies. More>>

ALSO:

Bottomless Oil And Zero Climate Cost: Greenpeace Not Big On PEPANZ Gas Ban Report

The NZIER report commissioned by oil industry body, PEPANZ, claims the oil and gas ban issued by the Government last April could cost the the New Zealand economy $28 billion by 2050... But Greenpeace says the figures in the report are based on false assumptions and alternative facts. More>>

ALSO:

Sunday Fruit Fly Update: Devonport Fruit And Veg Lockdown

Work continues at pace on the biosecurity response following the discovery last week of one male Queensland fruit fly in a surveillance trap in the Auckland suburb of Devonport. More>>

ALSO:

Digital Services Tax: Government To Plan Tax On Web Operator Income

New Zealand is to consult on the design of changes to tax rules which currently allow multinational companies in the digital services field to do business here without paying income tax. More>>

ALSO: